基于二维的技术在瘤学:一个新兴的途径
Joydip Sengupta1, Chaudhery Mustansar Hussain2
1Department of Electronic Science, Jogesh Chandra Chaudhuri College, Kolkata - 700033, India. joydipdhruba@gmail.com.
Nanoscale
|October 14, 2024
概括
是一种类全方位,由于其独特的特性,对癌症治疗具有前景. 在瘤学研究中临床使用必须克服稳定性和毒性方面的挑战.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 是一种二维类,具有独特的电子,机械和生物化学特性.
- 它的生物相容性和表面反应性使其成为生物医学应用的候选者.
研究的目的:
- 审查烯在瘤学中的新兴应用.
- 评估其在癌症治疗和研究中的潜在作用.
- 确定挑战和未来的研究方向.
主要方法:
- 关于烯在瘤学中的最新科学文献的批判性审查.
- 关于的特性和应用的研究成果的综合.
- 对临床翻译的挑战分析.
主要成果:
- 由于其特性,表明了癌症治疗和研究的潜力.
- 关键的挑战包括稳定性,毒性和可扩展的生产.
- 对于临床翻译,需要进一步的研究.
结论:
- 烯在推进瘤学方面具有重大前景.
- 解决目前的局限性对于实现其治疗潜力至关重要.
- 未来的研究应该专注于克服临床应用的稳定性和毒性问题.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K